<DOC>
	<DOCNO>NCT02785822</DOCNO>
	<brief_summary>Polycystic ovary occurs 15-20 % population submit TRA . Whether associate sign symptom ( polycystic ovarian syndrome ) present isolation , therapeutic management special connotation sometimes favor low response although standard tendency hyperresponsiveness . Although study compare combination FSH LH FSH control hyperstimulation patient , previous prospective randomize study compare administration urinary FSH ( hFSH-HP ) combination FSH HCG ( HMG HP ) . Therefore aim study prove drug comparable treatment patient . The test substance market Spain ( Fostipur Meriofert , respectively ) indication use patient . In study medicine administer randomized way usual condition use routine clinical practice compare quantity mature oocytes respect total oocyte obtain , primary outcome measure .</brief_summary>
	<brief_title>Study Compare hFSH-HP ( Fostipur ) hMG-HP ( Meriofert ) Patients With Polycystic Ovary Under IVF/ICSI Cycle .</brief_title>
	<detailed_description />
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>Female age 18 38 year ( inclusive ) Women BMI 30 kg / m2 Diagnosis polycystic ovary syndrome ( accord criterion Rotterdam ) Women want pregnancy Basal basal FSH level equal 10 IU / l Infertility justify treatment vitro fertilization / intracytoplasmic sperm injection To include protocol GnRH antagonist Presence ovaries uterus able support embryo implantation pregnancy Absence pregnancy start ovarian stimulation Written consent Severe male factor allow vitro fertilization / intracytoplasmic sperm injection ejaculate sample Patients low ovarian reserve Important endocrinemetabolic systemic disease affect pituitary , thyroid , adrenal , pancreas , liver kidney HIV seropositivity To freeze embryos previous cycle assist reproduction Undiagnosed vaginal haemorrhage Poor response previous cycle vitro fertilization standard stimulation protocol Pregnancy , lactation contraindication get pregnant Malformations sexual organ incompatible pregnancy History allergy gonadotrophin preparation excipients Alcohol , drug psychotropic addiction Concurrent participation another study Previous history severe hyperstimulation syndrome Concomitant medication may interfere study medication : different hormonal treatment use study , thyroid hormone , antipsychotic , anxiolytic , hypnotic , sedative , chronic treatment inhibitor prostaglandin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Reproductive Techniques , Assisted</keyword>
</DOC>